The Candida genus comprises opportunistic fungi that can become pathogenic when the
immune system of the host fails. Candida albicans is the most important and prevalent …

Undeniably, new antifungal treatments are necessary against pathogenic fungi. Fungal
infections have significantly increased in recent decades, being highlighted as important …

Microorganisms are remarkable producers of a wide diversity of natural products that
significantly improve human health and well-being. Currently, these natural products …

Candida albicans, one of the pathogenic Candida species, causes high mortality rate in
immunocompromised and high-risk surgical patients. In the last decade, only one new class …

Candida spp. is the major causative agent of fungal infections in hospitalized patients and
the fourth most common cause of nosocomial bloodstream infection (BSI). The availability of …

Human pluripotent embryonic stem cells have two special features: self-renewal and
pluripotency. It is important to understand the properties of pluripotent stem cells and …

Candida auris is an emerging multidrug-resistant pathogen implicated in numerous
outbreaks worldwide, with a notably high mortality rate (ca. 60%). A significant challenge …

In recent decades, the incidence of invasive fungal infections has increased notably.
Candida albicans (C. albicans), a common opportunistic fungal pathogen that dwells on …

Expanding the antifungal drug arsenal for treating Candida infections is crucial in this era of
the rising life expectancy of patients with immunosuppression and comorbidities. Infections …

The limited therapeutic options and the recent emergence of multidrug-resistant Candida
species present a significant challenge to human medicine and underscore the need for …